SLNO - Soleno Therapeutics Inc
IEX Last Trade
48.99
2.425 4.950%
Share volume: 475,543
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$46.56
2.43
5.21%
Summary score
11%
Profitability
0%
Dept financing
14%
Liquidity
58%
Performance
10%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-35.79%
Return on assets
-15.98%
Return on sales
-80942.18%
Return on invested capital
-2049.37%
Total debt ratio
36.38%
Debt ratio change over timeo
0.55%
Current Ratio
6.21%
Quick Ratio
3.73%
Cash Position Ratio
5.67%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-35.01%
Return on assets
-16.62%
Return on sales
0%
Return on invested capital
-71.09%
Total debt ratio
45.93%
Debt ratio change over timeo
1.8%
Current Ratio
5.05%
Quick Ratio
0%
Cash Position Ratio
4.97%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-13.14%
Return on assets
-10.59%
Return on sales
0%
Return on invested capital
-98.56%
Total debt ratio
28.76%
Debt ratio change over time
-1.24%
Current Ratio
7.53%
Quick Ratio
0%
Cash Position Ratio
7.47%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-286.21%
Return on assets
-147.07%
Return on sales
737195.52%
Return on invested capital
-367.75%
Total debt ratio
54.98%
Debt ratio change over time
0.55%
Current Ratio
25.16%
Quick Ratio
-12.03%
Cash Position Ratio
28.25%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | SLNO | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -35.79% | -3.05% | 11.55% | 6.27% |
| Return on assets | -15.98% | 3.6% | 3.57% | 5.27% |
| Return on sales | -80942.18% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | -2049.37% | 5.09% | 7.99% | 13.19% |
| Profitability | 0% | 46% | 82% | 83% |
| Total debt ratio | 36.38% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | 0.55% | 6.09% | 6.03% | 1.53% |
| Dept financing | 11% | 50% | 43% | 14% |
| Current Ratio | 5.05% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 4.97% | 1.48% | 0.76% | 1.49% |
| Liquididy | 75% | 18% | 39% | 41% |
| Short-term ratios | SLNO | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -35.01% | -25.62% | 17.94% | 7.14% |
| Return on assets | -16.62% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | -71.09% | 8.14% | 7.17% | 18.16% |
| Profitability | 0% | 49% | 79% | 82% |
| Total debt ratio | 45.93% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | 1.8% | -23.44% | 9.66% | 0.6% |
| Dept financing | 16% | 25% | 45% | 8% |
| Current Ratio | 5.05% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 4.97% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 35% | 29% | 50% |